Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-02-10

FDA Approved: TAFLUPROST OPHTHALMIC — Original Application (Prasco Laboratories)

View source ↗

Summary

FDA approves tafluprost ophthalmic solution under an original application for Prasco Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TAFLUPROST OPHTHALMIC (TAFLUPROST)

Snippet

ORIG AP for TAFLUPROST OPHTHALMIC (TAFLUPROST)